Literature DB >> 22627267

Hepcidin and iron regulation in health and disease.

Robert T Means1.   

Abstract

A decade ago, hepcidin, an antimicrobial peptide with iron-regulatory properties, was discovered and proposed as playing a significant role in the pathogenesis of anemia of chronic disease. Subsequent studies have demonstrated that hepcidin is the keystone of the linked systems of iron balance and iron transport in health and in disease. The definition of the role of hepcidin and its regulation has permitted the mechanisms of disorders of iron homeostasis to be understood at a molecular level. Future studies may identify roles for hepcidin or hepcidin-related molecules in diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22627267      PMCID: PMC3430792          DOI: 10.1097/MAJ.0b013e318253caf1

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

2.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 3.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

Review 4.  Inherited disorders of iron metabolism.

Authors:  Clara Camaschella; Erika Poggiali
Journal:  Curr Opin Pediatr       Date:  2011-02       Impact factor: 2.856

5.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

Review 6.  Iron-refractory iron deficiency anemia.

Authors:  Karin E Finberg
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

Review 7.  The etiology of the anemia of chronic disease and infection.

Authors:  S Kent; E D Weinberg; P Stuart-Macadam
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

8.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.

Authors:  Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

  8 in total
  11 in total

1.  Double bull's eye for post-operative intravenous iron in patient blood management: better outcome and cost-effective.

Authors:  Giancarlo M Liumbruno; Gioia Grazzini
Journal:  Blood Transfus       Date:  2013-12-04       Impact factor: 3.443

Review 2.  Importance of endocytic pathways in liver function and disease.

Authors:  Barbara Schroeder; Mark A McNiven
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

3.  Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms.

Authors:  Alus M Xiaoli; Ziyi Song; Fajun Yang
Journal:  J Biol Chem       Date:  2019-07-03       Impact factor: 5.157

Review 4.  Serum testosterone levels and excessive erythrocytosis during the process of adaptation to high altitudes.

Authors:  Gustavo F Gonzales
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

Review 5.  Measurement of posttransfusion red cell survival with the biotin label.

Authors:  Donald M Mock; John A Widness; Peter Veng-Pedersen; Ronald G Strauss; Jose A Cancelas; Robert M Cohen; Christopher J Lindsell; Robert S Franco
Journal:  Transfus Med Rev       Date:  2014-04-05

6.  Genetic variant coding for iron regulatory protein HFE contributes to hypertension, the TAMRISK study.

Authors:  Kirsi M Määttä; Seppo T Nikkari; Tarja A Kunnas
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

7.  Minor variant of rs 16827043 in the iron regulator hemojuvelin gene (HJV) contributes to hypertension: The TAMRISK study.

Authors:  Seppo T Nikkari; Anni-Laura Visto; Kirsi M Määttä; Tarja A Kunnas
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.

Authors:  Daniel Landau; Lital London; Inbar Bandach; Yael Segev
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

Review 9.  Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters.

Authors:  Robert T Means
Journal:  Nutrients       Date:  2020-02-11       Impact factor: 5.717

10.  Predicting hepcidin level using inflammation markers and iron indicators in patients with anemia of chronic disease.

Authors:  Ketut Suega; Gde Raka Widiana
Journal:  Hematol Transfus Cell Ther       Date:  2019-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.